![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen -- Pfizer Pain Collaboration Reaches First-in-Man Milestones
July 29, 2010 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., July 29, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on its sodium channel program for pain and related disorders, which is being...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
AGTC and Icagen Announce Technology Transfer Agreement
June 24, 2010 08:00 ET
|
Icagen, Inc.
ALACHUA, Fla. and RESEARCH TRIANGLE PARK, N.C., June 24, 2010 (GLOBE NEWSWIRE) -- AGTC, a privately held company, and Icagen, Inc. (Nasdaq:ICGN) today announced the completion of an agreement for the...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Reports First Quarter 2010 Financial Results and Operational Highlights
May 07, 2010 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., May 7, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the first quarter ended March 31, 2010. For...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen to Report First Quarter 2010 Results on May 7, 2010
April 28, 2010 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 28, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced plans to release first quarter 2010 financial results on Friday, May 7, 2010 before the...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Provides Update Regarding Clinical Development Plans for ICA-105665
April 27, 2010 08:35 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 27, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today provided an update on clinical development plans for ICA-105665, the Company's novel drug candidate...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
ICA-105665 Phase IIa Epilepsy Data to be Presented at the Tenth Eilat Conference on New Antiepileptic Drugs
April 21, 2010 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., April 21, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced that results from a study of ICA-105665 in patients with photosensitive epilepsy will be...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Reports Fourth Quarter and Full Year 2009 Financial Results and Operational Highlights
March 30, 2010 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 30, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) reported today its financial results and operational highlights for the fourth quarter and full year ended...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen to Announce Fourth Quarter and Full Year 2009 Results and Conduct Conference Call on March 30, 2010
March 18, 2010 08:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 18, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today announced it will release financial results for the fourth quarter and full year 2009 on Tuesday,...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Reports Positive Results for ICA-105665 in Patients With Photosensitive Epilepsy
March 15, 2010 17:00 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 15, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported positive results in its Phase IIa epilepsy study of ICA-105665, the Company's novel orally...
![Icagen, Inc. Logo](/news-release/logo/217869/0/217869.jpg?lastModified=12%2F09%2F2016%2023%3A18%3A31&size=2)
Icagen Reports Results of Phase Ib Pain Study of ICA-105665
March 01, 2010 16:30 ET
|
Icagen, Inc.
RESEARCH TRIANGLE PARK, N.C., March 1, 2010 (GLOBE NEWSWIRE) -- Icagen, Inc. (Nasdaq:ICGN) today reported results of its Phase Ib pain study of ICA-105665, the Company's novel orally available small...